Skip to content

Pain Relief Patch Versus Oral Tablet After Root Canal Treatment

Comparative evaluation of two different drugs administered using the transdermal drug delivery route versus two oral tablets in the management of postendodontic pain: A randomized controlled clinical trial - TREAT-PAIN

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000061652
Enrollment
80
Registered
2026-05-22
Start date
2024-03-18
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-Endodontic Pain

Interventions

Medicine: Ketoprofen transdermal patch A ketoprofen 30 mg transdermal patch was applied once to intact skin immediately after endodontic treatment in adult patients. The patch was replaced after 24 h

Sponsors

NIMS University, Jaipur, Rajasthan, India
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients aged 18 to 60 years 2.Patients diagnosed with symptomatic irreversible pulpitis or symptomatic apical periodontitis Multi-rooted teeth indicated for single-visit root canal treatment 3. Patients experiencing moderate to severe preoperative pain 4. Systemically healthy individuals 5. Patients willing to participate and comply with follow-up protocol

Exclusion criteria

Exclusion criteria: 1. Patients with a known history of hypersensitivity or adverse reactions to diclofenac, ketoprofen, or other non-steroidal anti-inflammatory drugs (NSAIDs), including reactions such as bronchospasm, shock, or urticaria, were excluded from the study. 2. Individuals with a history of active gastric or duodenal ulceration within the previous six months were not included. 3. Patients who were currently receiving NSAIDs or corticosteroid therapy during the study period were excluded. 4. Participants with a medical history of systemic conditions such as bronchial asthma, epilepsy, inflammatory bowel disease, severe hepatic or renal impairment, dengue fever, or any psychological or psychiatric disorders were not considered eligible for inclusion. 5. Pregnant and lactating women were excluded from the study. 6. Patients with a history of antibiotic use during the study period were also excluded.

Design outcomes

Primary

MeasureTime frame
Assessment of post-endodontic pain intensity using the Visual Analog Scale (VAS) at different time intervals following root canal treatment.

Secondary

MeasureTime frame
Assessment of adverse effects, need for rescue medication, and patient acceptance of transdermal and oral analgesic therapies following endodontic treatment.

Countries

Asia(except Japan)

Contacts

Public ContactCHITRA KUMARI

NIMS DENTAL COLLEGE & HOSPITAL, NIMS UNIVERSITY, RAJASTHAN, JAIPUR Conservative Dentistry & Endodontics

chitramallick100@gmail.com+919304336032

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026